Preclinical assessment of the novel compound EL102 in prostate cancerAidan Toner(Ollscoil na Gaillimhe – University of Galway)ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway)March 31, 201510.13025/16677Cited by 0SaveCiteExport RISWatch citationsRelated PapersThe novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance|British Journal of Cancer|2013|12